Guided Therapeutics, Inc.
GTHP
$0.1088
$0.00888.80%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.89% | 3.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.63% | -14.35% | |||
| Operating Income | 4.81% | 14.35% | |||
| Income Before Tax | 0.31% | 7.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.31% | 7.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.31% | 7.76% | |||
| EBIT | 4.81% | 14.35% | |||
| EBITDA | 4.83% | 14.26% | |||
| EPS Basic | 5.79% | 10.37% | |||
| Normalized Basic EPS | 6.85% | 9.88% | |||
| EPS Diluted | -59.50% | 10.37% | |||
| Normalized Diluted EPS | 6.85% | 9.88% | |||
| Average Basic Shares Outstanding | 7.94% | 1.88% | |||
| Average Diluted Shares Outstanding | 7.94% | 1.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||